Patents by Inventor Lance J. Bronnenkant

Lance J. Bronnenkant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8450299
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: May 28, 2013
    Assignee: Teva Womans's Health, Inc.
    Inventors: Charles E. Diliberti, Kathleen Z. Reape, Lance J. Bronnenkant
  • Patent number: 8415332
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: April 9, 2013
    Assignee: Teva Woman's Health, Inc.
    Inventors: Charles E. Diliberti, Kathleen Z. Reape, Lance J. Bronnenkant
  • Publication number: 20120252767
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Application
    Filed: June 8, 2012
    Publication date: October 4, 2012
    Applicant: Teva Women's Health, Inc.
    Inventors: Charles E. Diliberti, Kathleen Z. Reape, Lance J. Bronnenkant
  • Publication number: 20110124611
    Abstract: The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Application
    Filed: October 26, 2010
    Publication date: May 26, 2011
    Applicant: TEVA WOMEN'S HEALTH, INC.
    Inventors: ROBERT G. BELL, CAROLE S. BEN-MAIMON, BEATA ISKOLD, LANCE J. BRONNENKANT, HOWARD HAIT, KATHLEEN Z. REAPE
  • Patent number: 7855190
    Abstract: The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: December 21, 2010
    Assignee: Teva Women's Health, Inc.
    Inventors: Robert G. Bell, Carole S. Ben-Maimon, Beata Iskold, Lance J. Bronnenkant, Howard Hait, Kathleen Z. Reape
  • Patent number: 7772219
    Abstract: The present invention provides extended cycle contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin. The disclosed extended cycle contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Grant
    Filed: May 3, 2004
    Date of Patent: August 10, 2010
    Assignee: Teva Women's Health, Inc.
    Inventors: Carole S. Ben-Maimon, Howard Hait, Kathleen Z. Reape, Lance J. Bronnenkant
  • Publication number: 20080125402
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Application
    Filed: August 17, 2007
    Publication date: May 29, 2008
    Applicant: Duramed Pharmaceuticals, Inc.
    Inventors: Charles E. Diliberti, Kathleen Z. Reape, Lance J. Bronnenkant
  • Publication number: 20040220152
    Abstract: The present invention provides extended cycle contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin. The disclosed extended cycle contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Application
    Filed: May 3, 2004
    Publication date: November 4, 2004
    Inventors: Carole S. Ben-Maimon, Howard Hait, Kathleen Z. Reape, Lance J. Bronnenkant
  • Patent number: 5842474
    Abstract: The present invention provides an IUD loading device which folds the extended portions of an IUD such that the IUD may be placed into an insertion tube.
    Type: Grant
    Filed: July 12, 1996
    Date of Patent: December 1, 1998
    Assignee: FEI Products, Inc.
    Inventors: Philip J. Blyskal, Lance J. Bronnenkant, George A. Clark
  • Patent number: 5370129
    Abstract: Methods and apparatus are disclosed for permitting a user to load an IUD into an IUD inserter within the confines of a tray and thereafter to safely insert the IUD into a patient's uterus to the proper depth while minimizing the risk of causing trauma to the uterine wall. An IUD inserter comprises an elongate shaft adapted to retain the arms of an IUD adjacent the distal end of the shaft, a slidable arm retainer mounted on the shaft adaptable to abut the outer portion of a patient's cervix, and a stop member adjustably mounted on the shaft so that the arm retainer is forced by the outer portion of a patient's cervix to abut the stop member as the IUD is advanced through the cervical canal of a patient to a preselected depth at the uterine fundus. An associated package permits an IUD having expandable arms thereon to be loaded into an arm retainer within the confines of the package immediately prior to insertion of the IUD into a patient's uterus.
    Type: Grant
    Filed: August 28, 1992
    Date of Patent: December 6, 1994
    Assignee: DB Inserters, Inc.
    Inventors: Juan Diaz, Lance J. Bronnenkant
  • Patent number: RE35636
    Abstract: Methods and apparatus are disclosed for permitting a user to load an IUD into an IUD inserter within the confines of a tray and thereafter to safely insert the IUD into a patient's uterus to the proper depth while minimizing the risk of causing trauma to the uterine wall. An IUD inserter comprises an elongated shaft adapted to retain the arms of an IUD adjacent the distal end of the shaft, a slidable arm retainer mounted on the shaft adaptable to abut the outer portion of the patient's cervix, and a stop member adjustably mounted on the shaft so that the arm retainer is forced by the outer portion of a patient's cervix to abut the stop member as the IUD is advanced through the cervical canal of a patient to a preselected depth at the uterine fundus. An associated package permits an IUD having expandable arms thereon to be loaded into an arm retainer within the confines of the package immediately prior to insertion of the IUD into a patient's uterus.
    Type: Grant
    Filed: October 24, 1995
    Date of Patent: October 21, 1997
    Assignee: DB Inserters, Inc.
    Inventors: Juan Diaz, Lance J. Bronnenkant